ArticleJournal of diabetes investigation2024
A real-world disproportionality analysis of semaglutide: Post-marketing pharmacovigilance data.
Yikuan Du et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it